Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
CALL
Jazz Pharmaceuticals
JAZZ
$16B
| $454K | ﹤0.01% |
2,700
-12,500
| -82% | -$2.15M |
|
|
NVO
4277
PUT
Novo Nordisk
NVO
$205B
| $453K | ﹤0.01% |
19,200
-145,000
| -88% | -$3.54M |
|
4278
PUT
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$52.4M
| $452K | ﹤0.01% |
5
-31
| -86% | -$2.61M |
|
4279
Foster
FSTR
$405M
| $452K | ﹤0.01% |
22,015
+61
| +0.3% | +$1.4K |
|
4280
PUT
NCR Voyix
VYX
$1.17B
| $452K | ﹤0.01% |
25,917
-3,749
| -13% | -$66.8K |
|
|
AKCA
4281
DELISTED
Akcea Therapeutics Inc
AKCA
| $451K | ﹤0.01% |
12,881
-1,484
| -10% | -$44.9K |
|
|
DNR
4282
CALL
DELISTED
Denbury Resources, Inc.
DNR
| $451K | ﹤0.01% |
72,800
+57,700
| +382% | +$288K |
|
|
SEND
4283
DELISTED
SendGrid, Inc.
SEND
| $451K | ﹤0.01% |
12,276
+5,654
| +85% | +$178K |
|
|
JKS
4284
PUT
JinkoSolar
JKS
$860M
| $450K | ﹤0.01% |
41,800
-78,400
| -65% | -$1.04M |
|
|
RYZ
4285
Ryerson Holding Corp
RYZ
$1.5B
| $450K | ﹤0.01% |
39,881
-3,682
| -8% | -$41.4K |
|
4286
iShares Select Dividend ETF
DVY
$24B
| $449K | ﹤0.01% |
4,495
-3,482
| -44% | -$349K |
|
4287
Lattice Semiconductor
LSCC
$18.4B
| $449K | ﹤0.01% |
56,261
+47,230
| +523% | +$349K |
|
4288
PUT
MKS Inc
MKSI
$20.7B
| $449K | ﹤0.01% |
5,600
+5,400
| +2,700% | +$493K |
|
4289
NN Inc
NNBR
$298M
| $449K | ﹤0.01% |
28,708
+19,222
| +203% | +$360K |
|
|
DSKE
4290
DELISTED
Daseke, Inc. Common Stock
DSKE
| $449K | ﹤0.01% |
55,949
+52,947
| +1,764% | +$474K |
|
|
DBD
4291
DELISTED
Diebold Nixdorf Incorporated
DBD
| $449K | ﹤0.01% |
99,618
+61,715
| +163% | +$450K |
|
|
GLUU
4292
PUT
DELISTED
Glu Mobile Inc.
GLUU
| $449K | ﹤0.01% |
60,300
-25,800
| -30% | -$174K |
|
4293
Kadant
KAI
$3.91B
| $448K | ﹤0.01% |
4,155
+2,470
| +147% | +$245K |
|
|
VNTR
4294
DELISTED
Venator Materials PLC
VNTR
| $448K | ﹤0.01% |
49,749
+38,936
| +360% | +$503K |
|
|
HOS
4295
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $447K | ﹤0.01% |
75,938
+32,298
| +74% | +$148K |
|
4296
Titan Machinery
TITN
$431M
| $446K | ﹤0.01% |
28,867
+27,263
| +1,700% | +$431K |
|
|
TTOO
4297
DELISTED
T2 Biosystems, Inc
TTOO
| $445K | ﹤0.01% |
12
+8
| +200% | +$263K |
|
|
SPPI
4298
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $445K | ﹤0.01% |
26,500
+24,800
| +1,459% | +$537K |
|
|
RP
4299
DELISTED
RealPage, Inc.
RP
| $445K | ﹤0.01% |
6,756
-97,653
| -94% | -$5.82M |
|
4300
Ecovyst
ECVT
$1.09B
| $444K | ﹤0.01% |
25,409
+10,775
| +74% | +$191K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.